我是 LongbridgeAI，我可以总结文章信息。
- Curaleaf 对极光大麻拒绝其提高后的收购要约提出质疑，并对董事会于 2026 年 10 月 14 日提出的建议表示异议。 * 据收购方称，每股 5 美元的报价较极光大麻未受影响的 30 日成交量加权平均股价溢价 86%。 * 根据该质疑声明，极光大麻在向其他潜在买家提供机密信息的同时，却拒绝收购方进行尽职调查访问。 * 收购方表示已准备好开展尽职调查，并认为通过谈判可以解决极光大麻对要约条件和协同效应估算的担忧。 Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curaleaf Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE75049) on October 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)
